Students in Skills Lab

KU School of Pharmacy

KU School of Pharmacy is a world-class research institution and one of the country’s premier pharmacy schools.

Degree Programs

Student in Lab

Pharm.D. Program

A doctor of pharmacy degree (Pharm.D) prepares students to become pharmacy practitioners in a wide variety of settings, including community and retail pharmacies, hospitals, managed care facilities and many more.
Student looking through microscope

Graduate Programs

KU School of Pharmacy offers graduate degrees in Medicinal Chemistry, Neuroscience, Pharmacology & Toxicology and Pharmaceutical Chemistry, as well as residencies in Pharmacy Practice.

Tradition of Excellence

#14
Nationally in NIH Funding
95%
NAPLEX first-time pass rate
#2
In U.S. for MPJE Pass Rate

More KU Pharmacy

KU Pharmacy students walk down the hill at graduation

Why KU Pharmacy?

You can get your Pharm.D. anywhere. So, why get your Pharm.D. from KU School of Pharmacy?
Student pharmacist works with a patient in a clinical setting

What Can You Do With a Pharm.D?

A Pharm.D. from KU provides graduates with diverse career options. Learn about the careers you could pursue with a Doctor of Pharmacy degree from KU.
Student pharmacist studies material in IV bag

Our Research

The KU School of Pharmacy is seventh in the nation in National Instutes of Health (NIH) funding.



School of Pharmacy News

Joe Heidrick at COVID vaccine clinic

LAWRENCE — Just weeks after COVID-19 shut down the university and much of the country, Dean Ronald Ragan began planning for the day a vaccine would arrive.

Bharat Madan, a postdoctoral researcher in the DeKosky lab, headed research into potential of the vFP16.02 antibody. Credit: Matheus Oliveira de Souza.

LAWRENCE — Much like coronavirus, circulating HIV-1 viruses mutate into diverse variants that pose challenges for scientists developing vaccines to protect people from HIV/AIDS.

Michael Wolfe

Michael Wolfe, the Mathias P. Mertes Professor of Medicinal Chemistry at the University of Kansas School of Pharmacy, will serve as chair of the National Institutes of Health’s (NIH) Drug Discovery for the Nervous System (DDNS) Study Section at the institute’s Center for Scientific Review.